Yutaka Hatori
Kawasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy.
Journal: Scientific reports
Published: January 09, 2024
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 02, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Journal: Cardiovascular endocrinology & metabolism
Published: May 29, 2023
Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine.
Journal: Journal of medical virology
Published: April 22, 2023
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021.
Journal: Internal medicine (Tokyo, Japan)
Published: August 09, 2022
Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study.
Journal: Journal of cardiology
Published: May 24, 2022
Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
Journal: Journal of cardiology
Published: May 05, 2022
Heterogeneity assessment of vaccine-induced effects using point-of-care surrogate neutralization test for severe acute respiratory syndrome coronavirus 2.
Journal: Journal of clinical laboratory analysis
Published: March 07, 2022
Polypharmacy influences the renal composite outcome in patients treated with sodium-glucose cotransporter 2 inhibitors.
Journal: Clinical and translational science
Published: June 24, 2021
Effectiveness and Safety of Rivaroxaban by General Practitioners - A Multicenter, Prospective Study in Japanese Patients With Non-Valvular Atrial Fibrillation (GENERAL).
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: April 05, 2021
Evaluation of a new point-of-care quantitative reverse transcription polymerase chain test for detecting severe acute respiratory syndrome coronavirus 2.
Journal: Journal of clinical laboratory analysis
Published: April 03, 2021
Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Journal: Diabetes technology & therapeutics
Published: July 30, 2020
Last Updated: 09/26/2026